European Archives - Page 612 of 1004 - European Medical Journal

Effects of Successive Switches to Different Biosimilars Infliximab on Immunogenicity in Chronic Inflammatory Diseases in Daily Clinical Practice

Immunogenicity constitutes an important concern since it is associated with lower clinical responses and more adverse events…

Postmenopausal Osteoporosis: A Mini Review

Osteoporosis is a systemic skeletal disease characterised by microarchitectural deterioration and high fragility of bone tissue, resulting in low bone…

Update on the Diagnosis and Anticoagulant Treatment of the Antiphospholipid Syndrome

Although aPL are reported in 1–5% of the general population,2 only a minority of these individuals will develop the clinical manifestations of APS. The incidence of APS…

Secukinumab in the Management of Psoriatic Arthritis: Current Perspectives

Psoriatic arthritis (PsA) belongs to the group of diseases known as spondyloarthritis (SpA). The impact of PsA is not limited to just skin and joints…

A Review of Adalimumab Biosimilars for the Treatment of Immune-Mediated Rheumatic Conditions

Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…

Real-World Experience of Apremilast in Treating Psoriatic Arthritis Patients with Comorbidities

Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…

Progress In Understanding Endometriosis

PELVIC pain in women with endometriosis may be caused primarily by a type of white blood cell called macrophages that have been modified because…

Exercise the Key to Relieving Period Pain

PERIOD pain symptoms can be alleviated through exercising on a treadmill, according to the results of a clinical trial. The study suggests that in those…

An interview with Andrea Palmer from Publicis Health Media

We recently met with Andrea Palmer, President of Publicis Health Media at the 2019 Cannes Lions Festival of Creativity. In this interview Andrea talks about the new generation of HCP and how the pharma industry can meet the changing consumer expectations, as well as her own career and leadership success.

Curious Future Insight Conference and the Future Insight Prize: Merck’s Fight for a Better Tomorrow

At the Curious2018 – Future Insight Conference, as part of Merck’s 350th anniversary, Stefan Oschmann, CEO, Merck, announced the Future Insight Prize.